BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38522951)

  • 41. The effect of adjuvant radiotherapy on oncological outcomes in patients with early-stage cervical carcinoma with only intermediate-risk factors: a propensity score matching analysis.
    Turkmen O; Kilic F; Tokalioglu AA; Cakir C; Yuksel D; Kilic C; Boran N; Kimyon Comert G; Turan T
    J Obstet Gynaecol; 2022 Oct; 42(7):3204-3211. PubMed ID: 35959796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laparoscopically assisted radical vaginal hysterectomy versus radical abdominal hysterectomy for the treatment of early cervical cancer.
    Kucukmetin A; Biliatis I; Naik R; Bryant A
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD006651. PubMed ID: 24085528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer.
    Varela Cagetti L; Gonzague-Casabianca L; Zemmour C; Lambaudie E; Houvenaeghel G; Provansal M; Sabatier R; Sabiani L; Blache G; Jauffret C; Ferré M; Mailleux H; Paciencia M; Tallet A
    Gynecol Oncol; 2021 Apr; 161(1):166-172. PubMed ID: 33563488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of oncological outcomes and major complications between laparoscopic radical hysterectomy and abdominal radical hysterectomy for stage IB1 cervical cancer with a tumour size less than 2 cm.
    Li Z; Chen C; Liu P; Duan H; Liu M; Xu Y; Li P; Zhang W; Jiang H; Bin X; Lang J
    Eur J Surg Oncol; 2021 Aug; 47(8):2125-2133. PubMed ID: 33781626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial protocol.
    Park SJ; Kong TW; Kim T; Lee M; Choi CH; Shim SH; Yim GW; Lee S; Lee EJ; Lim MC; Chang SJ; Lee SJ; Lee SH; Song T; Lee YY; Kim HS; Nam EJ
    BMC Cancer; 2022 Mar; 22(1):331. PubMed ID: 35346103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radical vaginal hysterectomy with extraperitoneal pelvic lymphadenectomy in cervical cancer.
    Savino L; Borruto F; Comparetto C; Massi GB
    Eur J Gynaecol Oncol; 2001; 22(1):31-5. PubMed ID: 11321490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy.
    Yessaian A; Magistris A; Burger RA; Monk BJ
    Gynecol Oncol; 2004 Jul; 94(1):61-6. PubMed ID: 15262120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison between robot-assisted radical hysterectomy and abdominal radical hysterectomy for cervical cancer: A multicentre retrospective study.
    Chen B; Ji M; Li P; Liu P; Zou W; Zhao Z; Qu B; Li Z; Bin X; Lang J; Wang H; Chen C
    Gynecol Oncol; 2020 May; 157(2):429-436. PubMed ID: 32067814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laparotomic radical hysterectomy versus minimally invasive radical hysterectomy using vaginal colpotomy for the management of stage IB1 to IIA2 cervical cancer: Survival outcomes.
    Yang EJ; Kim NR; Lee AJ; Shim SH; Lee SJ
    Medicine (Baltimore); 2022 Feb; 101(8):e28911. PubMed ID: 35212297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the survival outcomes of laparoscopic, abdominal and gasless laparoscopic radical hysterectomy for early-stage cervical cancer: trial protocol of a multicenter randomized controlled trial (LAGCC trial).
    Tang X; Zhou S; Zhang X; Hua K; He Y; Wang P; Teng Y; Feng W
    Front Oncol; 2023; 13():1287697. PubMed ID: 38023150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
    Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
    Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of the clinical efficacy of different treatments based on radical surgery in stage Ⅰ b2 and Ⅱa2 cervical cancer: a prospective randomized control study].
    Li X; Kong WM; Han C; Yan Z; Zhao H; Zhang WY; Wang JD
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):524-9. PubMed ID: 27465872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laparoscopic nerve-sparing radical hysterectomy without uterine manipulator for cervical cancer stage IB: description of the technique, our experience and results after the era of LACC trial.
    Kavallaris A; Chalvatzas N; Gkoutzioulis A; Zygouris D
    Arch Gynecol Obstet; 2021 Apr; 303(4):1039-1047. PubMed ID: 33068159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer.
    Huang Y; Chen L; Cai J; Yang L; Sun S; Zhao J; Xiong Z; Wang Z
    World J Surg Oncol; 2022 Aug; 20(1):264. PubMed ID: 35996118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.
    Tsuruga T; Fujimoto A; Kawana K; Mori M; Hasumi Y; Kino N; Tomio K; Miura S; Tanikawa M; Sone K; Miyamoto Y; Ikeda Y; Kojima S; Adachi K; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Nakagawa S; Horie K; Yasugi T; Yokota H; Osuga Y; Fujii T
    Int J Clin Oncol; 2016 Apr; 21(2):359-366. PubMed ID: 26438230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102).
    Katsumata N; Yoshikawa H; Kobayashi H; Saito T; Kuzuya K; Nakanishi T; Yasugi T; Yaegashi N; Yokota H; Kodama S; Mizunoe T; Hiura M; Kasamatsu T; Shibata T; Kamura T;
    Br J Cancer; 2013 May; 108(10):1957-63. PubMed ID: 23640393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?
    Kamelle SA; Rutledge TL; Tillmanns TD; Gould NS; Cohn DE; Wright J; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Aug; 94(2):249-55. PubMed ID: 15297159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conization, frozen section examination, and planned hysterectomy in the treatment of high-grade cervical intraepithelial neoplasia.
    Carvalho JP; Carvalho FM; Pincerato KM; Pereyra EA
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(6):169-72. PubMed ID: 11836539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Close vaginal margins as a prognostic factor after radical hysterectomy.
    Estape RE; Angioli R; Madrigal M; Janicek M; Gomez C; Penalver M; Averette H
    Gynecol Oncol; 1998 Mar; 68(3):229-32. PubMed ID: 9570971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radical Hysterectomy After Neoadjuvant Chemotherapy for Locally Bulky-Size Cervical Cancer: A Retrospective Comparative Analysis between the Robotic and Abdominal Approaches.
    Liu CH; Lee YC; Lin JC; Chan IS; Lee NR; Chang WH; Liu WM; Wang PH
    Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31614465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.